Qube Research & Technologies LTD Belite Bio, Inc Transaction History

Qube Research & Technologies LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$12.53 - $36.64 $6,578 - $19,236	525 New	525 $16,000
Q1 2023 May 15, 2023	SELL	$25.61 - $33.5 $79,211 - $103,615	-3,093 Reduced 29.12%	7,528 $225,000
Q4 2022 Feb 14, 2023	BUY	$25.08 - $33.32 $4,489 - $5,964	179 Added 1.71%	10,621 $320,000
Q3 2022 Nov 14, 2022	BUY	$22.57 - $44.0 $85,811 - $167,288	3,802 Added 57.26%	10,442 $353,000
Q2 2022 Aug 15, 2022	BUY	$8.87 - $34.28 $58,896 - $227,619	6,640 New	6,640 $207,000

78.7K

Ticker BLTE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,867,400
Market Cap $2.06B
Description
Belite Bio, Inc, a clinical-stage biopharmaceutical drug development company, engages in the research and development of novel therapeutics targeting atrophic age-related macular degeneration and autosomal recessive stargardt diseases. Its lead product candidate is LBS-008, an oral once-a-day treatment that can reduce and maintain the delivery o...

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

Stay updated on Qube Research & Technologies LTD with notifications on news.